Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Biden’s Pick for Top FDA Job Has Prescribed Cannabis-Based Medicine

President Joseph Biden isn’t a big fan of broad, comprehensive cannabis reform. Even though plenty of Democrats and even some Republicans have thrown their weight behind broad legalization, Biden favors decriminalizing cannabis, legalizing medical cannabis, and giving states the freedom to craft their own marijuana policies. This has been a bone of contention for many lawmakers, especially those from the left, and Senate Majority Leader Chuck Schumer stated that he would advance broad federal legalization with or without the president. A recent move by Biden may be a sign of his preference for medical cannabis.

On Friday, Biden announced that he has nominated a new Food and Drug Administration (“FDA”) commissioner who, coincidentally, has acknowledged that cannabis has medical potential and has even prescribed a cannabinoid-based drug as a physician. A cardiologist by trade, Robert Califf served as the 22nd FDA commissioner from February 2016 to January 2017 after President Barack Obama nominated him in 2015. Prior to that, he had been serving as the deputy commissioner of the United States Food and Drug Administration’s Office of Medical Products and Tobacco. He was hired by Alphabet Inc. (Google’s parent company) in 2019 as the head of Medical Strategy and Policy.

Califf is a tenured professor of cardiology at the Duke University School of Medicine, and he is the founding director of what is said to be the largest academic research organization on the globe, the Duke Clinical Research Institute. While he hasn’t been very vocal about cannabis, he made his views on the subject known during a 2016 cannabis research summit hosted by the federal government. He acknowledged that the controversial plant has several medical applications and said that the FDA was interested in advancing cannabis research and development.

He mentioned the treatment of epilepsy, AIDS wasting, cancer, neuropathic pain, spasticity, multiple sclerosis, and cancer as well as chemotherapy-induced nausea as some of the possible uses of cannabis and cannabinoid-infused products. Furthermore, he stated that he had prescribed cannabis-related treatments to patients afflicted with wasting cachectic syndrome due to extreme heart failure in his cardiology practice. Even though the FDA may not have found that cannabis can be a safe and effective treatment, he said at the time thatit doesn’t mean the drug has zero good uses. Califf added that we need additional studies to learn more about marijuana’s possible risks and benefits.

In 2019, he authored an op-ed advocating for strict regulation of vapes and the ban of flavored vape products to reduce the risks of lung disease in the wake of the 2019 vape lung illness outbreak. He later said that an outright ban on all vape products would be impractical and that prohibition would perpetuate a stigma that would keep addicts from seeking treatment.

If Califf takes office as FDA commissioner, there is hope that he will be less hostile to the products made by cannabis companies such as Hero Technologies Inc. (OTC: HENC) since he has some experience with the therapeutic potential of marijuana products.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – AmeriCann (ACAN) Announces 300% Annual Revenue Increase from Flagship Project

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today announced financial and operational updates for its flagship project, the Massachusetts Cannabis Center. Located on a 52-acre parcel in southeastern Massachusetts, the project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure, which is being developed in phases to support multiple tenants in medical and adult-use cannabis markets. “AmeriCann’s operating revenue for the year ending September 2021 increased by over 300% from the prior year,” said CFO Ben Barton. “The strong top-line growth reflects four consecutive quarters of accelerating revenue. We look forward to releasing our complete quarterly and annual financial results as they are completed next month.”

To view the full press release, visit https://cnw.fm/c7JoD

About AmeriCann

AmeriCann develops and leases cannabis cultivation, processing and product manufacturing facilities. The company uses greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25% fewer lights, and utility bills are up to 75% less than in typical warehouse cultivation facilities. As such, AmeriCann’s “Cannopy” cultivation system enables cannabis to be produced with a greatly reduced carbon footprint, making the final product less expensive. Additionally, greenhouse construction costs are nearly half of warehouse construction costs. AmeriCann is also designing GMP Certified cannabis extraction and product manufacturing infrastructure. The company has secured licenses to produce cannabis infused products including beverages, edibles, topicals and concentrates. AmeriCann plans to operate a marijuana product manufacturing business at the Massachusetts Cannabis Center. For more information about the company, visit www.AmeriCann.co.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – New Cannabis Initiative to Push for Federal Legalization Launched

As more states across the United States legalize cannabis for medical and recreational use, the push to federally legalize the herb grows. Thus far, 18 states and Washington, DC, have legalized the recreational adult use of cannabis. Still, cannabis remains illegal to sell, use or possess under federal law, which has in turn made banks refrain from backing the marijuana industry, for fear that it would cause federal issues. Now major marijuana companies are supporting celebrity-infused campaigns to enlist cannabis users to pressure Congress to legalize the plant countrywide.

Earlier last week, the Cannabis in Common initiative was launched to make it easier for supporters to call or email their congressional representatives. State-licensed companies also plan to add more information to their applications, display posters in shops, email their consumers and encourage customers to get involved.

The cofounder of a marijuana firm, Seth Rogen, who is also an actor, stated that legalizing marijuana was long overdue, adding that it would happen if enough noise was made. In addition, prolegalization groups that have mounted federal and state campaigns for a long time now hope that this new initiative will break ground by mobilizing consumers of major players’ products in the marijuana industry.

U.S. Cannabis Council CEO Steve Hawkins stated that the council felt there existed a bigger group of people whose opinion on the matter of legalization would be helpful but was unheard.

More than 10 firms have signed on to the initiative, including publicly traded corporations such as Cronos Group, Curaleaf Holdings,Canopy Growth, and Pax, which is a vaping brand.

However, while most are in support of this move, there are those who criticize it, believing that it goes against all that is right. This includes Smart Approaches to Marijuana, a national marijuana anti-legalization group. Kevin Sabet, who is the CEO of the group and a former official under the Obama administration, stated that the campaign was putting profit over public health.

Additionally, a number of pro legalization not-for-profit groups are also keeping away from this initiative. This includes the Drug Policy Alliance, which believes that the campaign isn’t committed to expunging past cannabis convictions and helping individuals and communities who have been overly affected by cannabis arrests and the war on drugs.

In addition to this, NORML, one of the oldest legalization groups in the country, is also steering clear of this campaign. The group’s political director, Justin Strekal, stated that it was instead focused on certain congressional measures to make cannabis legal on the federal scale.

If these initiatives eventually bear fruit, a lot more people are likely to get comfortable trying medical cannabis, and this would provide an opportunity for helpful platforms such as RYAH MD, which is owned by RYAH Group Inc. (CSE: RYAH), to serve more people.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Montana Committee Recommends Reversal of CBD Ban in Cannabis Shops

Earlier this year, the governor of Montana signed House Bill 701 into law, setting the stage for Montana to launch a recreational cannabis market in January 2022. Sponsored by Republican Representative Mike Hopkins, the legislation allowed the sale of adult-use cannabis in counties that had voted in favor of the legalization initiative to adults 21 and older and charged the state Department of Revenue with developing administrative rules and issuing recreational cannabis business licenses. However, two proposed rules by the department drew the ire of industry stakeholders who claimed that the rules were not correct interpretations of the legalization bill.

Officials from the Department of Revenue have informed the Revenue Interim Committee that they have listened to several comments from individuals who are unsatisfied with the proposed rules. According to Cannabis Control Division attorney Courtney Cosgrove, the revenue department is now working to align the proposed rules with the recreational cannabis framework that was signed into law in May. But with the recreational market set to begin sales on Jan. 1, 2022, the department has a tight window to make the necessary changes.

According to Cosgrove, members of the committee meet once a week to every two weeks to discuss the proposed rules for Montana’s forthcoming recreational cannabis market. One of the rules that raised eyebrows was a proposed ban on the sale of CBD (cannabidiol) products in marijuana dispensaries. House Bill 701 requires that legal industrial hemp have less than 0.3% THC, the main chemical agent responsible for marijuana’s psychoactive effects. The state’s revenue department assumed that this ban also extended to CBD, which isn’t psychoactive.

Senate Minority leader Jill Cohenour argued that the ban wasn’t in line with the cannabis legislation’s provisions. She was part of a bipartisan working group that carried the bill through the Senate, and she says that lawmakers have also heard complaints about the proposed ban on CBD products. With demand for cannabidiol-infused products at an all-time high, the CBD market is projected to be worth $19.5 billion by 2025. Unsurprisingly, plenty of producers were preparing to cash in on the lucrative CBD market before the proposed CBD ban sent them into a panic.

The other contentious rule would have given the state revenue department the ability to revoke or suspend a cannabis worker who had been convicted of any crime or a cannabis-related crime in another state. This proposed rule was especially controversial because it would essentially punish the people who were already being punished by prohibition and prevent them from getting gainful employment. J.D. Pepper Petersen, a key figure in the 2020 legalization campaign, says the department should empower individuals to obtain any legal work they can, not put up even more barriers to employment.

Such a ban on the sale of CBD products in recreational cannabis ports would be extremely unfair to even far-off dedicated companies such as Simply Sonoma Inc., which manufacture CBD medicinal products that are in compliance with federal law.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Global Technologies Ltd (GTLL) Announces LOI to Acquire Tersus Power

Global Technologies (OTC: GTLL), a holding corporation with operations engaged in the online sales of CBD and hemp-related products, the acquisition of intellectual property in the safety and security space, and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, distribution and logistics, today announced its entry into a letter of intent to acquire Tersus Power. Tersus is focused on designing a safe, adaptable and affordable hydrogen fueling station that allows for rapid development and deployment of hydrogen fueling infrastructure while minimizing the risk to investors. “This is an exciting time for the Global Technologies shareholders,” said Jimmy Wayne Anderson, president of Global Technologies Ltd. “Tersus brings with it a management team with acute leadership skills and a world-class engineering lineup.”

To view the full press release, visit https://cnw.fm/Tejbj

About Global Technologies Ltd

Global Technologies, based in St. Petersburg, Florida, is a holding corporation, which, through its subsidiaries, has operations engaged in the online sales of CBD and hemp-related products, the acquisition of intellectual property in the safety and security space, and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, product placement in brick-and-mortar retail outlets and logistics. For further information, please visit the company’s website at www.GlobalTechnologiesLtd.info.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — How the Fashion Industry Is Giving Hemp Fiber a Hand Up

Farmers were allowed to legally cultivate industrial hemp after the 2018 farm bill was passed. Before the plant was banned, it was widely grown in different parts of the country. The plant’s seed, grain and fiber are used in different industries, including the pharmaceutical, animal care, construction and fashion industries.

Retailers and consumers in the fashion industry are keen on using the plant in their many processes, as it provides a sustainable alternative to synthetic materials as well as cotton. This interest continues to grow as the environmental crisis in fashion also intensifies.

Synthetic fibers are cheaper to mass produce, which may explain why they account for 60% of global fiber consumption. The issue isn’t mass production; rather, it’s the minute pieces of plastic shedding from clothes made from these materials that are the problem. These micro-plastics make up almost 35% of micro-plastics in the ocean.

Additionally, natural fibers require a lot of resources for production to occur. For instance, cotton needs roughly 712 gallons of water in order to produce a T-shirt from the material.

This makes the use of hemp fiber, which is not only sustainable but also biodegradable, appealing. However, before its fiber can be produced on a large scale, the United States needs to reconstruct its infrastructure.

Patagonia Materials Developer’s Alexandra LaPierre, stated that hemp was a low-till crop that needed very little water as well as no pesticides, which made the process of cultivating the plant a naturally sustainable practice. Most farmers in America use hemp as a rotation crop as it replenishes nutrients in the soil.

In order to decrease the waste produced by fast fashion and alleviate climate change, companies are focused on using more sustainable ways to afford consumers trendy styles while also producing less waste. Some companies are already developing solutions to help build an ecosystem around industrial hemp by investing millions that will facilitate the advancement of hemp processing technologies, linking the supply chain and connecting farmers to different partners in the country.

One of these companies is Bastcore, which revealed that it had received about $3 million in financing, which will be used to advance its decortication and degumming technology. Decortication refers to the stripping of the outer layer of the plant. On the other hand, degumming helps separate the plant’s fiber from its woody core and also removes pectins and sticky lignins.

The company plans to employ a huge workforce in order to meet the fashion market’s demand for industrial hemp in the future. As companies such as Flora Growth Corp. (NASDAQ: FLGC) expand their hemp textile operations, demand for hemp strains specifically developed for fiber production is likely to surge.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom athttps://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Factors Impacting Users’ Marijuana Experience

With more than three-quarters of all American states now allowing some form of cannabis, the controversial plant is more accessible to the public than it has ever been. No longer is cannabis associated with drug addicts and criminals; normal folk are incorporating cannabis into their routines while remaining valuable members of society. However, many users fail to get the effects they seek from cannabis due to the plant’s unique nature. Unlike most drugs, cannabis affects people differently depending on a wide variety of factors.

Your reason for consuming marijuana. What do you wish to gain from using cannabis? Are you looking to alleviate chronic pain or anxiety? Are you trying to focus and boost your creativity or would you rather relax and mellow out on the couch? Using cannabis for pain relief will not have the same experience compared to someone looking to beat insomnia or alleviate an inflammatory skin condition.

The type of product you use will have a major effect on your experience. Choosing a product that doesn’t align with your goal may not result in the experience you were looking for. The cannabis industry is diverse, and companies have developed formulations for a wide variety of functions, including alleviating pain, inducing sleep and improving recovery times after exercise. Picking a product that aligns with your goal will be integral to having an enjoyable experience with cannabis.

The strain or brand. Different varieties of cannabis will have varying cannabinoid levels. Some strains or brands could have a lot of THC and minimal CBD, another may have a lot of CBD but a little THC, while another one may have equal amounts of THC and CBD. Cannabis also produces terpenes and flavonoids that could affect the overall experience. Read up on the strain or brand you wish to buy to ensure you get the effects you are looking for.

The method of consumption. Cannabis has a wide variety of consumption options, and each of them impacts users differently. Smoking flower and vaping will result in almost immediate results as the cannabinoids in the smoke are absorbed into the bloodstream once it reaches the lungs. The effects kick in within two to five minutes and last anywhere from an hour to three hours. On the other hand, edibles take 30 minutes to an hour to kick in, with the effects peaking in around two hours and lasting for up to 24 hours.

Dose. As expected, the dose you consume will be directly tied to your experience. A certain dose of THC may leave you feeling relaxed and happy, another could leave you filled with anxiety, and another may boost your focus and creativity, In most cases, a higher dose of cannabis will cause adverse effects like nausea and general discomfort, so experts recommend a minimum dose of one to five milligrams for beginners. Your experience will also depend on your rate of consumption, meaning how long you wait between doses, as well as whether you’ve eaten or not.

Coupled with a clean, healthy lifestyle and smart choices, cannabis can be a valuable addition to your life. It’s going to be a trial-and-error process, especially if you’re a beginner. Take it slow, starting with minimal doses, and work your way through a variety of products to find the one that best suits your needs.

With entities such as Cannabis Strategic Ventures Inc. (OTC: NUGS) manufacturing a huge array of cannabis products, it helps to do your homework so that you choose exactly what will address your needs as a marijuana user.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Poll Shows Most Americans Support Cannabis Legalization

Over the past couple of years, public opinion on cannabis has seen a significant shift. After decades of prohibition, anti-cannabis rhetoric and harsh sentencing, plenty of people didn’t look too favorably on the controversial plant. But as more states have launched medical cannabis markets and marijuana’s possible benefits have come to light, public support for cannabis legalization has been on the rise. This has been reflected in a couple of surveys, with a recent poll by Rasmussen Reports finding that a majority of Americans support the national legalization of cannabis.

More specifically, 62% of the survey participants said that they were in favor of national legalization. Interestingly, 54% of Republicans said they supported legalization compared to 68% of Democrats and 62% of those who claimed another political affiliation. When asked whether they thought legalization should be left to the federal, state or local authorities, 47% said they favored the federal government, 32% felt legalization should be a state decision, and 11% preferred to have local authorities in charge. In addition, 53% of the participants said that they lived in a state with a legal cannabis market, and 38% lived in states that didn’t allow cannabis.

Furthermore, 50% of the respondents said that they had smoked the substance in the past while 45% reported that they hadn’t. Most of the respondents who support cannabis legalization in the country skewed younger. Only those aged 65 and older (40%) and those with incomes of more than $200,000 did not report majority support for national cannabis reform. This is the second poll over the past week to demonstrate the support for cannabis legalization among the general public. A Gallup survey released a few days ago revealed that 68% of adults in America backed legalizing marijuana, similar to what a Gallup poll found in November 2020.

Lawmakers are currently hard at work on drafting federal legalization bills. Senate Majority Leader Chuck Schumer, Senate Finance Committee Chairman Ron Wyden and Senator Cory Booker are working on a bill that would federally deschedule cannabis, and Republican Rep. Nancy Mace is set to unveil a bill that would federally legalize and tax marijuana to the House.

In September the House Judiciary Committee approved the Marijuana Opportunity, Reinvestment and Expungement (“MORE”) Act a week after it voted in favor of a defense bill that contained language protecting banks that work with businesses in the state-legal cannabis sector.

Despite all the public support for cannabis legalization and efforts by lawmakers to craft cannabis reform, Biden still doesn’t support broad legalization. He prefers modest reform that would decriminalize cannabis at the federal level, legalize medical use and grant states the freedom to determine their own cannabis policies.

If federal marijuana law reform is finally implemented, cannabis sector actors such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) will have a more conducive environment within which to operate, as well as a much bigger market to serve.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Bill Allowing Researchers to Study Cannabis from Dispensaries Advanced to President’s Desk

Last week, the House of Representatives passed an infrastructure legislation that includes provisions which will permit researchers to conduct research on the cannabis that consumers purchase from state-legal dispensaries.

This bill, which has been advanced to President Joe Biden’s desk, also encourages states that have enacted laws to legalize marijuana to educate individuals on impaired driving. A study that was funded by the federal government found that the amount of THC in an individual’s system after they had consumed cannabis wasn’t a reliable predictor of impairment.

Despite this finding, however, the measure directs that the transportation secretary work with the secretary of health and human services and the attorney general to compile a public report in two years, which should include recommendations on permitting researchers to access retail-level cannabis to conduct research on impaired driving.

A provision in the legislation also states that the report should contain a recommendation on the establishment of a national clearinghouse, which will gather and distribute strains and samples of cannabis for scientific research, including cannabis and products containing cannabis that is lawfully available to consumers or patients on a retail basis in a particular state

In another interview, Sen. John Hickenlooper stated that citizens in the country supported the legalization of cannabis, noting that the measure being enacted into law would be a step forward toward researching how the government could regulate marijuana-impaired driving accurately as well as safely.

This move by the House comes as Democratic legislators in Congress work on advancing different cannabis legalization measures, including a federal measure that was approved in September by the House Judiciary Committee.

Separately, the House Veterans’ Affairs Committee also approved an initiative last week that directs the Department of Veterans Affairs to carry out clinical trials on the medical benefits of cannabis for military veterans with chronic pain and post-traumatic stress disorder.

Additionally, the DEA recently suggested that a significant increase be made to the production of psilocybin and cannabis for research purposes. The agency’s objective is to assist in the development of new therapeutic medications, which will be federally approved.

The agency has also released a notice announcing that it plans to approve the applications of different firms, which will allow said companies to become federally authorized marijuana manufacturers. The marijuana will be used for research purposes.

In an interview, Nora Volkow, director of the National Institute on Drug Abuse, asserted that allowing researchers to study marijuana from state-licensed dispensaries was scientifically valuable.

These different efforts by advocates point to the possibility that sooner rather than later, marijuana may be decriminalized federally and industry players such as American Cannabis Partners will have fewer hoops to jump through as they grow their operations beyond state borders.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How to Calculate THC Levels in Marijuana Edibles

THC, or delta-9 tetrahydrocannabinol, is the chemical agent responsible for marijuana’s psychoactive effects. When ingested, the effects of THC tend to be stronger and last longer, meaning any dosage mistakes can leave users feeling uncomfortably high for hours. In fact, many a first-time user has ingested too much THC and vowed never to consume cannabis again due to the intense and often uncomfortable experience.

So how exactly would you calculate THC levels in marijuana edibles at home without access to scientists and fancy machines?

The first thing you should do is find out the cannabinoid content in the cannabis flower you plan to use. This will include THCA, the precursor to THC. In cannabis flower, THCA usually converts to THC once the flower is combusted in a process called decarboxylation, but in the case of edibles, you will have to heat your flower in butter or high-quality oil. The amount of THC that will convert to THC is referred to as the decarb rate and will determine the final dosage of edibles. The recommended dose for beginners is one to five milligrams of THC with one equaling 1,000 milligrams. Once you’ve settled on a dose, it’s time to estimate the decarb rate.

Let’s assume 90% of the THCA in your flower will decarb into THC. The next step will be to estimate the extraction efficiency, meaning the amount of THC that will be extracted from the flower and infused into the oil or butter. Most experts set the average extraction efficiency at 30% to 40% but we’ll assume a 60% extraction efficiency to stay on the safe side.

Once you know how much THC your flower contains and you have the decarb rate and extraction efficiency down, you’ll have to do a little math. Presuming you use 10g of cannabis flower with 20% THC, giving you a total of 2,000mg THC, your formula would be 2,000mg x 0.9, or the amount of THC x decarb rate.

This would give you a THC yield of 1,800 mg, which you would then multiply by the extraction efficiency of 60%; 1,800 x 0.6 would result in oil or butter infused with 1,080mg of THC, enough for 216 5mg portions. Regardless of the decarb rate and extraction efficiency estimates you use, you should multiply the amount of cannabis by the decarb rate and then multiply the answer by the extraction efficiency rate. Do the math several times. Furthermore, make sure you mix the oil or butter thoroughly to ensure THC is evenly distributed.

Cannabis manufacturers such as Hero Technologies Inc. (OTC: HENC) often have edibles of varying potency, so it is good to acquaint yourself with a method to calculate how much THC is in each serving, especially if you are using cannabis for medicinal purposes.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.